Steven Cohen Point72 Asset Management
Steven Cohen is the founder of Point72 Asset Management and previously built SAC Capital into one of the industry’s most profitable trading firms. Point72 operates a multi-manager platform combining fundamental long/short equity with systematic and other strategies. Cohen is also a major figure in sports ownership and philanthropy, while remaining one of the most closely followed names in hedge fund trading culture.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$195M |
| 2 |
Comcast
CMCSA
|
+$164M |
| 3 |
APC
Anadarko Petroleum
APC
|
+$157M |
| 4 |
AB InBev
BUD
|
+$151M |
| 5 |
FDC
First Data Corporation
FDC
|
+$139M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TWX
Time Warner Inc
TWX
|
+$414M |
| 2 |
AABA
Altaba Inc
AABA
|
+$290M |
| 3 |
Sherwin-Williams
SHW
|
+$229M |
| 4 |
Danaher
DHR
|
+$215M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$169M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.63% |
| 2 | Consumer Discretionary | 13.23% |
| 3 | Energy | 9.87% |
| 4 | Communication Services | 8.96% |
| 5 | Industrials | 7.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EXAS
226
DELISTED
Exact Sciences
EXAS
| $28.7M | 0.12% |
+546,806
| New | +$29.2M |
|
227
Celanese
CE
$5.14B
| $28.6M | 0.12% |
266,885
+194,585
| +269% | +$20.7M |
|
228
Marriott International
MAR
$92.9B
| $28.5M | 0.12% |
209,800
+92,200
| +78% | +$11.3M |
|
229
United Therapeutics
UTHR
$22B
| $28.4M | 0.12% |
+191,999
| New | +$24.4M |
|
230
Baker Hughes
BKR
$61.9B
| $28M | 0.12% |
885,080
+804,322
| +996% | +$25.8M |
|
|
RSPP
231
DELISTED
RSP Permian, Inc.
RSPP
| $28M | 0.12% |
687,600
-672,600
| -49% | -$24.2M |
|
232
Molina Healthcare
MOH
$10.5B
| $27.8M | 0.12% |
+363,066
| New | +$26.2M |
|
233
United Parks & Resorts
PRKS
$2.06B
| $27.8M | 0.12% |
+2,048,838
| New | +$25.5M |
|
234
Invesco QQQ Trust
QQQ
$486B
| $27.8M | 0.12% |
178,200
+172,700
| +3,140% | +$26.4M |
|
235
Haemonetics
HAE
$4.95B
| $27.7M | 0.12% |
+477,200
| New | +$25.1M |
|
236
Cencora
COR
$60.7B
| $27.7M | 0.12% |
301,259
-613,320
| -67% | -$50.7M |
|
|
PE
237
DELISTED
PARSLEY ENERGY INC
PE
| $27.6M | 0.12% |
939,200
-4,769,978
| -84% | -$127M |
|
|
HDS
238
DELISTED
HD Supply Holdings, Inc.
HDS
| $27.6M | 0.12% |
690,172
+70,569
| +11% | +$2.59M |
|
|
ERF
239
DELISTED
Enerplus Corporation
ERF
| $27.5M | 0.12% |
2,804,702
+903,312
| +48% | +$8.24M |
|
240
PUT
Kroger
KR
$35.5B
| $27.4M | 0.12% |
+1,000,000
| New | +$23.3M |
|
|
TWX
241
PUT
DELISTED
Time Warner Inc
TWX
| $27.4M | 0.12% |
+300,000
| New | +$28.3M |
|
242
Etsy
ETSY
$7.44B
| $27.4M | 0.12% |
+1,339,325
| New | +$23.6M |
|
243
Sinclair Inc
SBGI
$1.04B
| $27.2M | 0.12% |
718,328
+436,228
| +155% | +$14.4M |
|
244
Build-A-Bear
BBW
$488M
| $27.1M | 0.12% |
2,949,976
+415,300
| +16% | +$3.54M |
|
245
Timken Company
TKR
$8.67B
| $27.1M | 0.12% |
550,893
+464,593
| +538% | +$22.5M |
|
246
Axalta
AXTA
$7.75B
| $26.9M | 0.12% |
+830,260
| New | +$26.3M |
|
|
ALXN
247
DELISTED
Alexion Pharmaceuticals
ALXN
| $26.6M | 0.12% |
222,737
+162,837
| +272% | +$19.8M |
|
|
ILG
248
DELISTED
ILG, Inc Common Stock
ILG
| $26.4M | 0.11% |
927,200
+275,686
| +42% | +$7.95M |
|
249
iRhythm Holdings
IRTC
$4.24B
| $26.3M | 0.11% |
470,099
+201,648
| +75% | +$10.5M |
|
|
BRFS
250
DELISTED
BRF SA
BRFS
| $26.3M | 0.11% |
2,332,717
+2,123,217
| +1,013% | +$27.1M |
|
Similar funds
Steven Cohen's Q4 2017 Portfolio in Review
As of Q4 2017, Steven Cohen held 1,233 positions worth $23.2B, up 3.4% from $22.4B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Steven Cohen's Q4 2017 filing shows 387 new, 243 increased, 233 reduced and 356 closed positions. Its largest new stake was Regeneron Pharmaceuticals: 481,354 shares worth $181M. The largest sale was Time Warner Inc, an estimated $414M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Energy.
- Steven Cohen's largest Q4 2017 buy was Regeneron Pharmaceuticals: 481,354 shares worth $181M.
- Steven Cohen added most to Comcast in Q4 2017, an estimated $164M increase.
- Steven Cohen's biggest Q4 2017 reduction was Time Warner Inc, cutting an estimated $414M.
- Steven Cohen fully exited Sherwin-Williams in Q4 2017, selling an estimated $229M.
- Steven Cohen's ten largest holdings make up 13% of its $23.2B portfolio in Q4 2017.
- Steven Cohen opened 387 new positions and closed 356 in Q4 2017.
- Steven Cohen's portfolio value rose 3.4% quarter-over-quarter to $23.2B.
Based on Point72 Asset Management's 13F filing for Q4 2017, filed 14 Feb 2018.